Who invested in ElsaLys Biotech?
ElsaLys Biotech's investors include Sofimac Partners and Transgene.

France · Series A startup
Funding summaryUpdated 26 Oct 2026
$2.7Mraised across 1 round since 2013, from 1 source
ElsaLys Biotech's investors include Sofimac Partners and Transgene.
ElsaLys Biotech has raised $2.7M across 1 round since 2013.
ElsaLys Biotech's most recent round was a Series A of $2.7M in May 2013.
Its most recent round, $2.7M in May 2013, is also its largest on record.
ElsaLys Biotech's first round on record, in May 2013, was backed by Sofimac Partners and Transgene.
ElsaLys Biotech's latest named round is a Series A, in May 2013.
ElsaLys Biotech is based in France.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.